Biodexa Pharmaceuticals Income Statement (2013-2025) | BDRX

Income Statement Dec2013 Dec2014 Dec2015 Jun2016 Dec2016 Jun2017 Dec2017 Jun2018 Dec2018 Jun2019 Dec2019 Jun2020 Sep2020 Dec2020 Jun2021 Sep2021 Dec2021 Jun2022 Sep2022 Dec2022 Jun2023 Dec2023 Jun2024 Dec2024 Jun2025 Dec2025
Revenue & Cost
Revenue (Quarter)
0.00B0.00B0.00B0.00B
Interest income
Interest Income - Deposits (Quarter)
0.00B0.00B0.00B0.00B0.00B
Interest Income - Total (Quarter)
-0.00B-0.00B-0.00B
Interest expenses
Interest Expenses (Quarter)
-0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B0.00B
Interest Income - Net (Quarter)
0.00B-0.00B-0.00B
Non-interest income
Financial Services Fees (Quarter)
Mortgage Banking (Quarter)
0.00B
Non-Interest Income (Quarter)
0.00B
Operating Items
Amortization - Intangibles (Quarter)
-0.01B-0.02B
Research & Development (Quarter)
-0.01B-0.01B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Restructuring Costs (Quarter)
-0.01B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Other Operating Expenses (Quarter)
-0.00B0.00B-0.00B
Operating Expenses (Quarter)
-0.02B-0.02B-0.01B-0.01B-0.01B-0.00B-0.01B-0.00B-0.01B-0.01B-0.01B
Operating Income (Quarter)
-0.02B-0.01B-0.02B-0.03B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B
EBIT (Quarter)
-0.02B-0.01B-0.02B-0.03B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.01B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
0.00B0.00B
Net income details
EBT (Quarter)
-0.02B-0.01B-0.02B-0.03B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B
Tax Provisions (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Profit After Tax (Quarter)
-0.02B-0.01B-0.01B0.00B-0.03B-0.01B-0.01B-0.00B-0.01B-0.00B-0.01B0.000.00
Income from Non-Controlling Interests (Quarter)
-0.00B-0.00B0.00B
Income from Continuing Operations (Quarter)
-0.02B-0.02B-0.02B-0.03B-0.01B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B
Consolidated Net Income (Quarter)
-0.01B-0.01B-0.00B-0.02B-0.03B-0.01B-0.01B-0.00B-0.01B-0.00B-0.01B-0.00B-0.01B
Income towards Parent Company (Quarter)
-0.01B-0.01B-0.00B-0.02B-0.02B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.01B
Preferred Dividend Payments (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B
Net Income towards Common Stockholders (Quarter)
-0.01B-0.01B-0.00B-0.02B-0.02B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.01B
Additional items
EPS (Basic) (Quarter)
-0.05-0.040.00-0.03-0.27-0.05-0.03-0.02-0.02-0.02-0.06-0.03-0.05
EPS (Diluted) (Quarter)
-0.05-0.11-0.01-0.01
Shares Outstanding (Quarter)
0.13B6,108.41B0.15B3.02B0.92B0.92B0.92B0.09B0.09B0.09B0.16B0.16B0.16B0.20B0.20B0.16B0.16B0.10B0.10B10.97B
Shares Outstanding (Diluted) (Quarter)
0.08B0.08B0.49B0.49B0.49B0.49B
EBITDA (Quarter)
-0.02B-0.01B-0.02B-0.03B-0.00B-0.00B-0.00B-0.00B-0.01B-0.01B-0.01B-0.01B